These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17575137)

  • 1. Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice.
    Robinson-Smith TM; Isaacsohn I; Mercer CA; Zhou M; Van Rooijen N; Husseinzadeh N; McFarland-Mancini MM; Drew AF
    Cancer Res; 2007 Jun; 67(12):5708-16. PubMed ID: 17575137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flt-3 ligand inhibits growth of human ovarian tumors engrafted in severe combined immunodeficient mice.
    Silver DF; Hempling RE; Piver MS; Repasky EA
    Gynecol Oncol; 2000 Jun; 77(3):377-82. PubMed ID: 10831345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor trap combined with paclitaxel strikingly inhibits tumor and ascites, prolonging survival in a human ovarian cancer model.
    Hu L; Hofmann J; Holash J; Yancopoulos GD; Sood AK; Jaffe RB
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6966-71. PubMed ID: 16203789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of the ovarian cancer microenvironment by SPARC.
    Said N; Socha MJ; Olearczyk JJ; Elmarakby AA; Imig JD; Motamed K
    Mol Cancer Res; 2007 Oct; 5(10):1015-30. PubMed ID: 17951402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human ovarian carcinomas in a SCID mouse model.
    Xu Y; Silver DF; Yang NP; Oflazoglu E; Hempling RE; Piver MS; Repasky EA
    Gynecol Oncol; 1999 Feb; 72(2):161-70. PubMed ID: 10021295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenger receptor-A-targeted leukocyte depletion inhibits peritoneal ovarian tumor progression.
    Bak SP; Walters JJ; Takeya M; Conejo-Garcia JR; Berwin BL
    Cancer Res; 2007 May; 67(10):4783-9. PubMed ID: 17510407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial-stromal interaction increases cell proliferation, survival and tumorigenicity in a mouse model of human epithelial ovarian cancer.
    Greenaway J; Moorehead R; Shaw P; Petrik J
    Gynecol Oncol; 2008 Feb; 108(2):385-94. PubMed ID: 18036641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissemination of intraperitoneal ovarian cancer: Discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model.
    Feki A; Berardi P; Bellingan G; Major A; Krause KH; Petignat P; Zehra R; Pervaiz S; Irminger-Finger I
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):1-9. PubMed ID: 19179094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of coagulation factor XII and monocyte/macrophages mediating peritoneal metastasis of epithelial ovarian cancer.
    Wang R; Zhang T; Ma Z; Wang Y; Cheng Z; Xu H; Li W; Wang X
    Gynecol Oncol; 2010 Jun; 117(3):460-6. PubMed ID: 20233624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulosa cell tumorigenesis in genetically hypogonadal-immunodeficient mice grafted with ovaries from tumor-susceptible donors.
    Beamer WG; Shultz KL; Tennent BJ; Shultz LD
    Cancer Res; 1993 Aug; 53(16):3741-6. PubMed ID: 8339285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization.
    Deng W; Gu X; Lu Y; Gu C; Zheng Y; Zhang Z; Chen L; Yao Z; Li LY
    Angiogenesis; 2012 Mar; 15(1):71-85. PubMed ID: 22210436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Establishment and comparison of two intraperitoneally transplanted human ovarian carcinoma models with immune reconstitution in severe combined immunodeficient mice].
    Li Y; Cui H; Chang XH; Feng J; Fu TY; Feng YJ; Wei LH
    Ai Zheng; 2004 Feb; 23(2):160-4. PubMed ID: 14960235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of intraperitoneally transplantated human ovarian carcinoma model with immune reconstruction in severe combined immunodeficient mice].
    Zhu H; Ye D; Chen H; Lu W; Xie X
    Zhonghua Yi Xue Za Zhi; 2002 May; 82(9):630-3. PubMed ID: 12133487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor necrosis factor therapy inhibits pancreatic tumor growth and metastasis.
    Egberts JH; Cloosters V; Noack A; Schniewind B; Thon L; Klose S; Kettler B; von Forstner C; Kneitz C; Tepel J; Adam D; Wajant H; Kalthoff H; Trauzold A
    Cancer Res; 2008 Mar; 68(5):1443-50. PubMed ID: 18316608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
    Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P
    Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17.
    Chiriva-Internati M; Grizzi F; Weidanz JA; Ferrari R; Yuefei Y; Velez B; Shearer MH; Lowe DB; Frezza EE; Cobos E; Kast WM; Kennedy RC
    J Immunol Methods; 2007 Apr; 321(1-2):86-93. PubMed ID: 17336323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).
    Ferreira MA; Barcelos LS; Teixeira MM; Bakhle YS; Andrade SP
    Life Sci; 2007 Jun; 81(3):210-7. PubMed ID: 17588613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection of human primary effusion lymphoma cells or associated macrophages into severe combined immunodeficient mice causes murine lymphomas.
    Zenger E; Abbey NW; Weinstein MD; Kapp L; Reis J; Gofman I; Millward C; Gascon R; Elbaggari A; Herndier BG; McGrath MS
    Cancer Res; 2002 Oct; 62(19):5536-42. PubMed ID: 12359765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel anti-inflammatory action of edelfosine lacking toxicity with protective effect in experimental colitis.
    Mollinedo F; Gajate C; Morales AI; del Canto-Jañez E; Justies N; Collía F; Rivas JV; Modolell M; Iglesias A
    J Pharmacol Exp Ther; 2009 May; 329(2):439-49. PubMed ID: 19244550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development.
    Montel V; Gaultier A; Lester RD; Campana WM; Gonias SL
    Cancer Res; 2007 Oct; 67(20):9817-24. PubMed ID: 17942912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.